FDA Drug recall D-0455-2017
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13)…
- FDA Drug
- Class II
- terminated
- Published 2017-02-08
On 2017-02-08 the FDA classified a Class II recall of Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13)… by Sun Pharmaceutical Industries, citing failed Dissolution Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0455-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-01-12 |
| Published | 2017-02-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Sun Pharmaceutical Industries |
| Distribution | US |
Product
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.
Reason
Failed Dissolution Specifications
Identifiers
| ndc | 62756-517-83 |
|---|---|
| ndc | 62756-517-88 |
| ndc | 62756-517-08 |
| ndc | 62756-517-13 |
| ndc | 62756-517-18 |
| ndc | 62756-518-83 |
| ndc | 62756-518-88 |
| ndc | 62756-518-08 |
| ndc | 62756-518-13 |
| ndc | 62756-518-18 |
| ndc | 62756-519-83 |
| ndc | 62756-519-88 |
| ndc | 62756-519-08 |
| ndc | 62756-519-13 |
| ndc | 62756-519-18 |
| ndc | 62756-985-01 |
| ndc | 62756-985-02 |
| code_info | a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0455-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.